If you’re struggling with

Depression, Anxiety, Addiction, Memory Problems or other Mental Health Issues, there is good reason for hope.

BEVERLY HILLS OFFICE

450 North Bedford Drive
Suite 307
Beverly Hills, CA 90210
office@drgandin.com

Office: (310) 497-8900
Fax: (310) 551-4131

About Dr. Gandin

Dr. Gandin has experience in treating various psychiatric disorders. His areas of expertise include the following:

  • Mood, Anxiety, and Psychotic Disorders

  • Addiction – Substance, Sex/Love, and Others

  • Geriatric Psychiatric Disorders, with the utilization of comprehensive memory evaluations

  • Women’s Mental Health (concerns about psychotropic medications during pregnancy & breast feeding)

  • Transgender Issues

Dr. Gandin received his Bachelor of Arts with a Major in Philosophy from the University of California at Berkeley. After completing medical school within the New York State/American Program at Tel Aviv University, Dr. Gandin performed his Internship and Residency in Psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA where he served as Chief Resident. He completed Fellowships in both Geriatric and Community Psychiatry there as well. In addition, he has received psychoanalytic training at the New Center for Psychoanalysis.

Dr. Gandin is licensed as a Physician and Surgeon by the Medical Board of California and is board certified in Psychiatry as a Diplomate of the American Board of Psychiatry and Neurology. He has been an Assistant Clinical Professor at the Semel Institute for Neuroscience and Human Behavior at UCLA and has supervised trainees within the UCLA Memory Disorders Clinic. Dr. Gandin is a member of and remains active in various organizations including the American Medical Association and the American Association for Geriatric Psychiatry.

https://openpaymentsdata.cms.gov

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.